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Summary Objectives: Infective endocarditis is common and data regarding its pat-
tern and outcome from developing countries is sparse. We therefore examined the
spectrum, demographics and clinical features of infective endocarditis and sought to
determine the factors affecting its clinical outcome.
Patients and methods: Over a ﬁve-year period at our university hospital in Karachi,
Pakistan, we identiﬁed 66 patients with infective endocarditis and compared their
clinicoepidemiologic features and outcomes to subjects in the West.
Results: The male:female ratio was 2:1; overall median age was 24 years (35.5
years for men and 13.5 years for women) (p < 0.001). Median duration of symptoms
before presentation was 20.5 days. Major predisposing cardiac abnormalities included
congenital (50%) and rheumatic (23%) lesions, and a history of heart surgery (17%).
Causative organisms and valvular sites of infection were similar to those seen in de-
veloped countries. Blood culture-negative infective endocarditis was found in 48% of
cases. Renal failure was more frequent among culture-positive patients (p = 0.055).
Risk factors for mortality included neurologic (p = 0.003) and embolic (p = 0.02) com-
plications, renal (p = 0.03) and left ventricular failure (p = 0.002), and a history of
cardiac surgery (p = 0.026). Overall mortality was 27%.
Conclusions: Patients with infective endocarditis in Pakistan exhibit signiﬁcant dif-
ferences compared to their counterparts in the West, including younger age at pre-
sentation, incidence of predisposing cardiac conditions, and gender differences re-
ﬂecting sociocultural bias. Neurologic and embolic complications, renal failure and
heart failure predict a worse outcome.
© 2004 International Society for Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.
Introduction
In the West, over the past three decades there
has been a shift in the age-related incidence of
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infective endocarditis from younger to more el-
derly patients. Acute rheumatic fever has de-
clined sharply (although rheumatic heart disease
is still a major risk factor for infective endo-
carditis in most developing countries) and degen-
erative valvular lesions have become the most
frequent anatomic abnormalities predisposing to
infection.1—7
1201-9712/$30.00 © 2004 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
doi:10.1016/j.ijid.2004.02.001
164 M. Tariq et al.
In industrialized nations, early correction of
congenital cardiac defects with subsequent risk
reduction for infection has also played a role in
the shift of underlying heart disease leading to
endocarditis.8—10 New developments in the diagno-
sis and management of infective endocarditis have
inﬂuenced the pattern of disease seen in developed
countries, particularly as related to early surgical
intervention and reduced mortality.2,4—7,11,27,36,37
Data regarding the pattern and outcome of infec-
tive endocarditis from developing countries are
sparse12—15 and there have been no large series of
endocarditis among adult patients reported from
Pakistan. We sought to determine the predisposing
factors, demographic and clinical characteristics,
and outcomes of patients with infective endocardi-
tis in our region of the world, and compare the
results with recent studies from the West.
Patients and methods
We retrospectively reviewed the medical records
of all patients admitted to the Aga Khan University
Hospital in Karachi, Pakistan, with a diagnosis of
infective endocarditis over a ﬁve-year period from
January 1997 to December 2001. The Aga Khan Uni-
versity Hospital has 537 beds and is both a primary
and tertiary care teaching institution serving the
8—12 million inhabitants of Karachi and those in
the surrounding Sindh province. The median num-
ber of annual admissions during the study period
was about 13,300 patients. Seventy-ﬁve cases of
infective endocarditis were identiﬁed by conduct-
ing a search of electronically-coded (International
Classiﬁcation of Diseases 9th revision with clin-
ical modiﬁcation, or ICD-9-CM) medical records
using the diagnoses ‘endocarditis’ or ‘infective
endocarditis’. In addition, the echocardiography
log book maintained by the cardiac diagnostic
laboratory was cross-checked for cases. All cases
reviewed underwent veriﬁcation of diagnosis ac-
cording to the modiﬁed Duke criteria11 and were
classiﬁed as either ‘deﬁnite’ or ‘possible’ cases
of infective endocarditis. After a ﬁnal review, 66
patients were included in this analysis.
The modiﬁed Duke criteria11 were used in the
diagnosis of infective endocarditis in our study
cohort, with deﬁnitions as follows: ‘deﬁnite’ en-
docarditis — the presence of two major criteria, or
one major and three minor criteria, or ﬁve minor
criteria; ‘possible’ endocarditis — one major and
one minor criterion or three minor criteria. In pa-
tients without major criteria, diagnosis was based
upon the presence of prolonged unexplained fever,
presence of a strong predisposing heart condition
(such as a valvular abnormality) or peripheral stig-
mata of endocarditis (e.g. vascular, immunologic),
echocardiographic features consistent with endo-
carditis but not meeting major echocardiographic
criteria, microbiologic or serologic evidence of ac-
tive infection but not meeting major criteria, and
the absence of any other explanation for fever
after extensive diagnostic investigation.
At our institution the microbiologic work-up
for patients with suspected infective endocardi-
tis, usually within the context of prolonged un-
explained fever, typically consists of 3—5 sets of
aerobic and anaerobic blood cultures, a periph-
eral blood smear for malaria parasites, and, where
appropriate, bone marrow biopsy and culture and
abdominal sonography.38 Fungal blood cultures
are obtainable38 but serologic testing for Coxiella
burnetti, fungi, and chlamydiae, Bartonella, and
Brucella species are generally not available.
Statistical interpretation of data was performed
using the computerized software program SPSS ver-
sion 10.0 (SPSS, Inc., Chicago IL, 1999). Univari-
ate analysis to determine prognostic indicators uti-
lized Pearson’s chi square, Fischer’s exact test, and
Student’s t test where appropriate. A p value of
<0.05 was considered statistically signiﬁcant.
Results
The annual number of infective endocarditis
episodes during the study period represented 0.99
per 1,000 hospital admissions. Thirty-three patients
(50%) were each classiﬁed as having ‘deﬁnite’ in-
fective endocarditis and ‘possible’ endocarditis,
respectively. Of those subjects with deﬁnite endo-
carditis, 24 satisﬁed both major criteria while nine
patients had one major and three minor criteria.
For patients with possible endocarditis, 19 had one
major criterion and two minor criteria, one patient
had one major criterion and one minor criterion,
and 13 patients had ≥three minor criteria. A ma-
jority of study patients had community-acquired
infection (62/66 patients; 94%).
Forty-four patients were male and 22 female
(male:female ratio 2:1). Patient ages ranged from
one month to 72 years, with a mean and median age
of 28.6 and 24 years, respectively. There were 22
patients under 15 years of age. There was a signiﬁ-
cant difference in the age at presentation between
men and women in our study cohort; the mean
and median age for men was 34.7 and 35.5 years,
respectively, compared to 16.5 and 13.5 years for
women (p < 0.001). The median duration of symp-
toms at time of presentation was 20.5 days (20 days
versus 30 days for men and women, respectively;
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Congenital heart disease 33 (50)
Rheumatic heart disease 15 (23)
History of cardiac surgery* 11 (17)
Prosthetic cardiac valve 5 (8)
Degenerative heart disease 1 (2)
Intravenous drug abuse 1 (2)
* Non-valve replacement.
p = 0.29), with a range of one to 365 days. Fever
was the most common presenting symptom (62/66
patients; 94%). A new heart murmur or change
in a previously-noted murmur was present in 57
(86%) patients, and splenomegaly was noted in 24%
(16/66 subjects). Congenital heart disease was the
most common underlying cardiac condition in our
patient population (50%) (Tables 1 and 2). Isolated
ventricular septal defect, Tetralogy of Fallot, mi-
tral stenosis, and mitral valve prolapse were the
most frequently encountered congenital disorders.
Rheumatic heart disease was present in 15 (23%)
patients. Degenerative, prosthetic, and IV drug
use-associated valvular lesions were uncommonly
seen.
Blood cultures were obtained for all 66 patients.
Almost one half of study subjects had persistently
negative blood cultures. Of 32 culture-negative pa-
tients, seven had deﬁnite endocarditis with onema-
jor and threeminor criteria. For 25 culture-negative
patients with possible endocarditis, 12 had one




Ventral septal defect 9 (14)
Mitral stenosis 5 (8)
Tetralogy of Fallot 5 (8)
Mitral valve prolapse 5 (8)
Bicuspid aortic valve 2 (3)
Mitral regurgitation 2 (3)
Aortic stenosis 2 (3)
Cleft mitral valve 1 (2)
Aortic regurgitation 1 (2)
Supravalvular pulmonary stenosis 1 (2)




* Two patients had multiple cardiac lesions.
Table 3 Microorganisms isolated from blood cul-




Viridans streptococci 12 (35)
Streptococcus bovis 1 (3)
Streptococcus mitis 1 (3)
Streptococcus intermedius 1 (3)
Other streptococcal species 5 (15)
Staphylococci 8 (24)
Staphylococcus epidermidis 5 (15)
Staphylococcus aureus 3 (9)
Enterococcus faecalis 1 (3)
Gram-negative organisms 5 (15)
Pseudomonas cepacia* 1 (3)
Pseudomonas maltophilia 1 (3)
Enterobacter cloacae+ 1 (3)
Enterobacter agglomerans 1 (3)
Serratia marcescens 1 (3)
Subtotal 34 (52)
No growth on culture 32 (48)
Total 66 (100)
* Prosthetic valve endocarditis.
+ Intravenous drug abuser.
major and one minor criterion, and 13 patients
had three to four minor criteria but no major cri-
teria. Streptococci (59%) were the most commonly
isolated organisms and viridans group streptococci
the most frequently recovered species (Table 3).
Staphylococci were present in 24% of patients,
although Staphylococcus aureus was recovered
from only three subjects. Both patients with ab-
scess formation on the aortic valve had large,
mobile vegetations on echocardiography; one grew
Staphylococcus aureus from blood while the other
had culture-negative infection. Five patients grew
Gram-negative bacilli from blood cultures; one of
these patients was an IV drug abuser.
An extra-cardiac source of infection was present
in 22 (33%) patients at the time of presentation,
and pneumonia (11 patients) was the most com-
mon condition diagnosed. Other relevant infections
included urinary tract infection (three patients),
sepsis (two patients), diabetic foot infection (two
patients), tuberculosis (two patients), bacterial
meningitis (one patient), and enteric fever (one
patient). Eleven patients had a history of previous
non-valve replacement cardiac surgery; ﬁve had
a prosthetic heart valve in place. A history of re-
cent dental surgery or manipulation could not be
retrieved from the patient records.
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Table 4 Sites of vegetations detected by echocar-
diography in 66 patients with infective endocarditis*.
Site Number of
patients (%)
Mitral valve 14 (21)
Aortic valve 15 (23)
Mitral + aortic valves 3 (5)
Tricuspid valve 3 (5)
Pulmonic valve 2 (3)
Ventriculoseptal defect 1 (2)
Interventricular septum (right side) 1 (2)
Moderator band in right ventricle 1 (2)
Patent ductus arteriosus 1 (2)
Pulmonary artery banding site 1 (2)
No vegetations on echocardiogram 22 (33)
* Echocardiography not performed in two patients.
Of the ﬁve patients with prosthetic valve infec-
tions, only one had positive blood cultures (Pseu-
domonas cepacia). Four of these patients had an
extra-cardiac source of infection that included
pneumonia (two patients) or sepsis (two patients).
Only two patients with prosthetic valve endocardi-
tis demonstrated vegetations and both had involve-
ment of the aortic valve. Three patients developed
neurologic complications (intracranial hemorrhage
(two patients) and stroke (one patient)) while one
subject developed renal failure.
Two-dimensional transthoracic echocardiog-
raphy (TTE) was performed in 61 patients and
transesophageal echocardiography (TEE) in 12 pa-
tients. Results of echocardiography are shown in
Table 4. Ten of 12 patients who underwent TEE
had detectable vegetations. Eleven patients had
moderate-to-severe aortic regurgitation, while
eight patients had moderate-to-severe mitral insuf-
ﬁciency. Two patients had an aortic root abscess;
both were diagnosed on TTE. Right-sided endo-
carditis was seen in ﬁve patients, with the tricuspid
valve involved in three patients and the pulmonic
valve in two patients. Extra-valvular cardiac in-
volvement included margins of a ventriculoseptal
defect, interventricular septum, right ventricu-
lar moderator band, patent ductus arteriosus, or
pulmonary artery banding site. Echocardiography
failed to show cardiac vegetations in 22 (33%) pa-
tients; all of these subjects underwent TTE and two
who had TEE performed as well. Echocardiography
was not carried out in two study patients because
they died within 24 hours of admission.
The most frequent extra-cardiac complications
in our study population were neurologic (21 of 66
patients; 32%). Neurologic events included cere-
bral embolism (nine patients), intracranial hem-
orrhage (ﬁve patients), seizures (ﬁve patients),
meningitis (one patient), and cerebral abscess
(one patient). Neurologic complications were the
largest single contributor to mortality. Renal com-
plications included microscopic hematuria (16 pa-
tients), renal failure (eight patients), and glomeru-
lonephritis (two patients). Eleven patients devel-
oped hemolytic anemia, ten patients had non-CNS
embolic phenomena, and two patients developed
a cardiac valve abscess. The most common cardiac
complication was left ventricular failure, which
was present in 24 patients (36%).
We compared the clinical and microbiologic char-
acteristics of culture-positive and culture-negative
patients (Table 5). Culture-negative patients
were likely to be younger and have a shorter
duration of symptoms at time of presentation.
Culture-positive patients were more likely to be
male, with a male:female ratio of 3:1. Renal fail-
ure was more common among culture-positive
patients, and this ﬁnding almost achieved sta-
tistical signiﬁcance (p = 0.055). All ﬁve patients
with mitral valve prolapse had culture-negative
infection (p = 0.023). There was no statistically
signiﬁcant difference between culture-positive
and culture-negative patients in terms of left ven-
tricular failure (p = 0.852), or overall medical or
surgical management.
Appropriate medical treatment was given to all
but one patient who left the hospital against med-
ical advice. Penicillin G (41 patients) and gentam-
icin (38 patients) were the most commonly admin-
istered antibiotics. Other antibiotics included cef-
triaxone (15 patients), cefotaxime (nine patients)
vancomycin (14 patients), cloxacillin (13 patients),
and rifampicin (one patient). Cardiac surgical in-
tervention was required for eight (12%) patients:
six patients had aortic valve replacement (ﬁve for
severe regurgitation and one for critical stenosis),
one patient had mitral valve replacement (for se-
vere regurgitation) and open drainage for a cere-
bral abscess, and one patient underwent closure
of a patent ductus arteriosus. Culture-negative pa-
tients were generally treated with penicillin G, cef-
triaxone, or cefotaxime with or without gentamicin
(Table 5).
In-hospital mortality was 27% (18/66 patients).
Of the 48 patients who recovered, 35 completed
antimicrobial therapy in the hospital before dis-
charge. For ﬁnancial reasons, ﬁve patients were
discharged from the hospital and completed their
therapy as outpatients. At the time of this report,
eight patients were lost to follow-up while 40 pa-
tients remain disease-free. There was no difference
in mortality for patients with positive versus nega-
tive blood cultures. Three patients with prosthetic
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Table 5 Comparison of culture-positive and culture-negative patients with infective endocarditis.
Feature Culture-positive No. (%) Culture-negative No. (%) p value
Number of patients 34 (52) 32 (48) 0.44
Median age (yrs) 32.5 20.5 0.50
Sex ratio (M:F) 3:1 1.3:1 0.08
Duration of symptoms (days) 30 12 0.30
Risk factors 20 (59) 18 (56) 0.19
Complications
Neurologic 9 (27) 12 (38) 0.33
Renal failure 7 (21) 1 (3) 0.055
Systemic emboli 5 (15) 5 (16) 0.91
Native valve involvement 15 (44) 24 (75) 0.48
Prosthetic valve involvement 2 (6) 4 (13) 0.19
Extra-valvular involvement 7 (21) 4 (13) 0.21
Vegetations on echo 24 (71) 18 (56) 0.22
No vegetations on echo 10 (29) 12 (38) 0.22
Antibiotics used
Penicillin 18 (53) 23 (72) 0.11
Gentamicin 15 (44) 23 (72) 0.023
Ceftriaxone 10 (29) 5 (16) 0.18
Cefotaxime 3 (9) 6 (19) 0.29
Cloxacillin 8 (24) 5 (16) 0.42
Vancomycin 9 (26) 5 (16) 0.28
Surgical treatment 3 (9) 5 (16) 0.46
Mortality 9 (27) 9 (28) 0.88
valve infection died during the course of hospital
stay, but there was no signiﬁcant difference in mor-
tality between patients with prosthetic and native
valve endocarditis (p = 0.120).
Patients who died had a longer duration of symp-
toms before presentation, and had more frequent
histories of cardiac surgery (33% versus 10%)
(p = 0.026) compared to patients who were
successfully treated (Table 6). Heart failure
(p < 0.002), neurologic complications (p < 0.003),
systemic emboli (p < 0.02), and renal failure
(p < 0.03) were signiﬁcantly associated with mor-
tality. Eleven patients died from neurologic com-
plications, with an attributable mortality of 61%
(11/18).
Discussion
In developed countries, the epidemiologic char-
acteristics of infective endocarditis have changed
over the past few decades. This shift is attributed
to a number of factors including increasing patient
longevity and a concomitant rise in cases of degen-
erative valvular lesions, a marked reduction in the
incidence of acute rheumatic fever, and more fre-
quent use of invasive central vascular catheters as-
sociated with an increase in nosocomially-acquired
endocarditis. Themedian age of patients with endo-
carditis fromwestern countries in the pre-antibiotic
era was about 35 years, and in subsequent decades
the age at presentation has gradually increased
to >50 years.3,5,16—32 In our study cohort, mean
and median age at the time of presentation were
29 and 24 years, respectively. A study from India
reported a similar mean age of 25 years13 and
may reﬂect the effect of rheumatic heart disease
and uncorrected congenital heart disease on rel-
atively younger persons in poorer regions of the
world.
Furthermore, there was a signiﬁcant difference
in the age at presentation between men and women
in our cohort; the mean and median age for men
was 34.7 and 35.5 years, respectively, compared to
16.5 and 13.5 years for women (p < 0.001). In Pak-
istani society, older women are less likely to have
access to medical treatment because of certain so-
cial factors. Accordingly, such an age difference
may reﬂect inherent cultural and referral bias. In
our study men were twice as likely to develop endo-
carditis as women, and male:female ratios as high
as 3.4:1 have been previously reported.6 Series of
endocarditis from the pre-antibiotic era did not de-
scribe any difference in gender prevalence.19,33,34
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Table 6 Comparison of patients with infective endocarditis who died and those who recovered.
Feature Died No. (%) Recovered No. (%) p value
No. of patients 18 (27) 48 (73) 0.44
Median age (years) 29 28 0.62
Sex ratio (male:female) 2:1 2:1 1:00
Duration of symptoms (days) 57 43 0.98
Predisposing conditions
Congenital 8 (44) 25 (52) 0.83
Rheumatic 3 (17) 12 (25) 0.74
History of cardiac surgery 6 (33) 5 (10) 0.026
Prosthetic cardiac valves 3 (17) 2 (4) 0.12
Intravenous drug abuse 0 1 (2) 1.00
Degenerative heart disease 0 1 (2) 1.00
Extra-cardiac site of infection 8 (44) 14 (29) 0.24
Complications
Neurologic 11 (61) 10 (21) 0.003
Renal failure 5 (28) 3 (6) 0.03
Systemic emboli 6 (33) 4 (8) 0.02
Heart failure 12 (67) 12 (25) 0.002
Vegetations on echocardiogram 12 (67) 30 (63) 0.75
Site of vegetations
Mitral valve 3 (17) 11 (23) 0.74
Aortic valve 5 (28) 10 (21) 0.54
Tricuspid valve 2 (11) 1 (2) 0.17
Pulmonic valve 0 2 (4) 1.00
Mitral + aortic valve 1 (6) 2 (4) 1.00
Other 1 (6) 4 (8) 1.00
Positive blood cultures 9 (50) 25 (52) 0.88
Streptococci 4 (22) 16 (33) 0.54
Staphylococci 3 (17) 5 (10) 0.67
Enterococci 0 (0) 1 (2) 1.00
Gram-negative 2 (11) 3 (6) 0.60
Negative blood cultures 9 (50) 23 (48) 0.88
Treatment
Antibiotics alone 17 (94) 41 (85) 0.43
Surgical intervention 1 (6) 7 (15) 0.43
Deﬁnite endocarditis 10 (56) 23 (48) 0.58
Probable endocarditis 8 (44) 25 (52) 0.58
The male predominance seen in our study cohort
is likely explained by sociocultural determinants of
access to health care within our society.
Congenital heart disease was the most fre-
quently encountered underlying condition in our
study population, in contrast to reports from other
developing countries where rheumatic heart dis-
ease is the commonest predisposing factor leading
to infective endocarditis.13,14 The predominance
of congenital heart disease might be explained
by the frequency of consanguineous marriages in
Pakistani society, and by the fact that options
for correction of congenital cardiac lesions are
extremely limited. The valvular site of infection
and the causative microorganisms were very simi-
lar to previous series of native valve endocarditis
described from both developed and third world
countries.16,20,25,32 Numbers of patients with pros-
thetic valve- and illicit drug use-associated infec-
tion were too small to make meaningful compar-
isons with other studies. Culture-negative endo-
carditis was seen in 48% of our study cohort, and
is likely attributed to the frequent use of antibi-
otics (prescribed or self-administered) by patients
prior to diagnosis.13,14 Patients who were blood
culture-positive were more likely to have renal
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failure (p = 0.055) than culture-negative subjects,
and patients with renal complications all showed
vegetations on echocardiography perhaps suggest-
ing a dominant mechanism of peripheral emboliza-
tion to the kidneys.
Watanakunakorn and Burkert17 and Gray35 re-
ported a lower mortality among blood culture-
negative patients in the US, in contrast to a recent
study by Zamorano and colleagues40 who found that
patients with negative blood cultures had a worse
outcome with a higher frequency of heart failure
and valve rupture or perforation, and a tendency
towards more a frequent need of surgical repair.
We did not ﬁnd any signiﬁcant difference in mortal-
ity between culture-positive and culture-negative
subjects.
In our study, TEE was performed in only 12 pa-
tients but with demonstrable vegetations seen
in ten of these subjects. Numerous studies have
conﬁrmed the greater sensitivity and speci-
ﬁcity of TEE compared to TTE in the detection
of endocarditis-associated heart abnormalities.
Kupferwasser and colleagues39 concluded that TEE
appears to be crucial in the diagnostic work-up of
patients with culture-negative endocarditis. These
same authors have also demonstrated enhanced
diagnostic validity of the Duke criteria in clinical
studies of culture-negative endocarditis.39
Overall mortality for our study patients was
27.3%, a ﬁgure similar to other series reported
from Asia but slightly higher than that reported
in western studies.13,17 One-third of our patients
who died from their infection had a history of car-
diac surgery, and this appeared to be a signiﬁcant
risk factor for mortality (p = 0.026). Left ventricu-
lar failure (p < 0.002) and renal failure (p < 0.03)
were more frequent among patients who died,
and Bouza and co-workers have previously demon-
strated that congestive heart failure and acute
renal failure are signiﬁcantly linked to mortality.37
Neurologic complications (p < 0.003) and systemic
emboli (p < 0.02) were also signiﬁcantly associated
with risk of death.
In summary, in our Pakistani cohort the clinical
presentation, site of valvular infection, and types of
etiologic microorganisms were typical of infective
endocarditis reported from the West. Nevertheless,
compared to patients with infective endocarditis
in developed countries, notable differences in our
study population included a younger age at time
of onset, higher incidence among women (likely
reﬂecting societal factors), and a greater propor-
tion of cases complicating congenital and rheumatic
heart disease. Patients with a history of cardiac
surgery and those with neurologic and embolic com-
plications had a poorer prognosis. The presence of
renal failure and heart failure also predicted risk of
mortality. Existing diagnostic criteria for endocardi-
tis can be applied to patients in Pakistan, allowing
accurate identiﬁcation of infected patients even in
the setting of negative blood cultures caused by fre-
quent self-administration of antimicrobial agents
before presentation.
Conﬂict of Interest: No conﬂicting interest de-
clared.
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